Antenatal Infections and Respiratory Outcome in Preterm Infants

Abstract

Fetal exposure to infection and inflammation can result in accelerated lung maturation and simultaneously altered lung development. This alteration is characterized by reduced alveolar and vascular formation that is one of the hallmarks of the changes observed in animal models and in infants with bronchopulmonary dysplasia (BPD). These opposite effects on maturation and on lung development can explain the reduced severity of respiratory distress syndrome (RDS) but increased incidence of BPD observed in infants exposed to antenatal infections. This also explains why infants born to mothers with chorioamnionitis or colonized with ureaplasma urealitycum have an increased risk of lung injury and BPD. Despite the negative effects of infection on lung development, there is no clear evidence that antibiotic therapy improves the respiratory course in these infants. While the administration of azithromycin to ureaplasma colonized infants is effective in eradicating airway colonization, the effect on BPD is inconclusive. One of the few interventions that have been shown to improve respiratory outcome and reduce BPD in infants with severe RDS is the modulation of inflammation by the administration of systemic or intratracheal steroids early after birth.

Key Points

• Antenatal infection can reduce RDS.

• Fetal exposure to infection can alter lung development and increase BPD.

• The detrimental effect of infection is enhanced by mechanical ventilation.

Keywords

prematurity - lung development - chorioamnionitis - bronchopulmonary dysplasia

Publication History

Article published online:
08 September 2020

• References

• 1 Morrow LA, Wagner BD, Ingram DA. , et al. Antenatal determinants of bronchopulmonary dysplasia and late respiratory disease in preterm infants. Am J Respir Crit Care Med 2017; 196 (03) 364-374
• 2 Stenmark KR, Abman SH. Lung vascular development: implications for the pathogenesis of bronchopulmonary dysplasia. Annu Rev Physiol 2005; 67: 623-661
• 3 Mestan KK, Gotteiner N, Porta N, Grobman W, Su EJ, Ernst LM. Cord blood biomarkers of placental maternal vascular underperfusion predict bronchopulmonary dysplasia-associated pulmonary hypertension. J Pediatr 2017; 185: 33-41
• 4 Tang JR, Karumanchi SA, Seedorf G, Markham N, Abman SH. Excess soluble vascular endothelial growth factor receptor-1 in amniotic fluid impairs lung growth in rats: linking preeclampsia with bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 2012; 302 (01) L36-L46
• 5 Abman SH. Bronchopulmonary dysplasia: “a vascular hypothesis”. Am J Respir Crit Care Med 2001; 164 (10 Pt 1): 1755-1756
• 6 Willet KE, Jobe AH, Ikegami M, Newnham J, Brennan S, Sly PD. Antenatal endotoxin and glucocorticoid effects on lung morphometry in preterm lambs. Pediatr Res 2000; 48 (06) 782-788
• 7 Kunzmann S, Speer CP, Jobe AH, Kramer BW. Antenatal inflammation induced TGF-beta1 but suppressed CTGF in preterm lungs. Am J Physiol Lung Cell Mol Physiol 2007; 292 (01) L223-L231
• 8 Bartram U, Speer CP. The role of transforming growth factor beta in lung development and disease. Chest 2004; 125 (02) 754-765
• 9 Polglase GR, Hooper SB, Gill AW. , et al. Intrauterine inflammation causes pulmonary hypertension and cardiovascular sequelae in preterm lambs. J Appl Physiol (1985) 2010; 108 (06) 1757-1765
• 10 Watterberg KL, Demers LM, Scott SM, Murphy S. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 1996; 97 (02) 210-215
• 11 Jobe AH. Effects of chorioamnionitis on the fetal lung. Clin Perinatol 2012; 39 (03) 441-457
• 12 Van Marter LJ, Dammann O, Allred EN. , et al; Developmental Epidemiology Network Investigators. Chorioamnionitis, mechanical ventilation, and postnatal sepsis as modulators of chronic lung disease in preterm infants. J Pediatr 2002; 140 (02) 171-176
• 13 Kumar R, Yu Y, Story RE. , et al. Prematurity, chorioamnionitis, and the development of recurrent wheezing: a prospective birth cohort study. J Allergy Clin Immunol 2008; 121 (04) 878-84.e6
• 14 Lahra MM, Beeby PJ, Jeffery HE. Maternal versus fetal inflammation and respiratory distress syndrome: a 10-year hospital cohort study. Arch Dis Child Fetal Neonatal Ed 2009; 94 (01) F13-F16
• 15 Villamor-Martinez E, Álvarez-Fuente M, Ghazi AMT. , et al. Association of chorioamnionitis with bronchopulmonary dysplasia among preterm infants a systematic review, meta-analysis, and metaregression. JAMA Netw Open 2019; 2 (11) e1914611
• 16 Viscardi RM. Ureaplasma species: role in neonatal morbidities and outcomes. Arch Dis Child Fetal Neonatal Ed 2014; 99 (01) F87-F92
• 17 Yoder BA, Coalson JJ, Winter VT, Siler-Khodr T, Duffy LB, Cassell GH. Effects of antenatal colonization with ureaplasma urealyticum on pulmonary disease in the immature baboon. Pediatr Res 2003; 54 (06) 797-807
• 18 Collins JJ, Kallapur SG, Knox CL. , et al. Inflammation in fetal sheep from intra-amniotic injection of Ureaplasma parvum. Am J Physiol Lung Cell Mol Physiol 2010; 299 (06) L852-L860
• 19 Nair V, Loganathan P, Soraisham AS. Azithromycin and other macrolides for prevention of bronchopulmonary dysplasia: a systematic review and meta-analysis. Neonatology 2014; 106 (04) 337-347
• 20 Viscardi RM, Terrin ML, Magder LS. , et al. Randomised trial of azithromycin to eradicate Ureaplasma in preterm infants. Arch Dis Child Fetal Neonatal Ed 2020; 0: F1-F8
• 21 Young KC, Del Moral T, Claure N, Vanbuskirk S, Bancalari E. The association between early tracheal colonization and bronchopulmonary dysplasia. J Perinatol 2005; 25 (06) 403-407
• 22 Novitsky A, Tuttle D, Locke RG, Saiman L, Mackley A, Paul DA. Prolonged early antibiotic use and bronchopulmonary dysplasia in very low birth weight infants. Am J Perinatol 2015; 32 (01) 43-48